Literature DB >> 23197711

Accumulation of α-synuclein triggered by presynaptic dysfunction.

Yasuto Nakata1, Toru Yasuda, Masahiro Fukaya, Saori Yamamori, Makoto Itakura, Tomoko Nihira, Hideki Hayakawa, Aya Kawanami, Masakazu Kataoka, Makiko Nagai, Hiroyuki Sakagami, Masami Takahashi, Yoshikuni Mizuno, Hideki Mochizuki.   

Abstract

Pathological examination of dementia with Lewy bodies patients identified the presence of abnormal α-synuclein (αSyn) aggregates in the presynaptic terminals. αSyn is involved in the regulation of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Importantly, αSyn-transgenic mouse and postmortem examination of patients with Parkinson's disease have demonstrated the abnormal distribution of SNARE protein in presynaptic terminals. In this study, we investigated the effects of SNARE dysfunction on endogenous αSyn using Snap25(S187A/S187A) mutant mice. These mice have homozygous knock-in gene encoding unphosphorylatable S187A-substituted synaptosomal-associated protein of 25 kDa (SNAP-25). The mice displayed a significant age-dependent change in the distribution of αSyn and its Ser(129)-phosphorylated form in abnormally hypertrophied glutamatergic nerve terminals in the striatum. Electron-microscopic analysis revealed the abnormally condensed synaptic vesicles with concomitant mislocalization of αSyn protein to the periactive zone in the glutamatergic nerve terminals. However, the Snap25(S187A/S187A) mutant mouse harbored no abnormalities in the nigrostriatal dopaminergic neurons. Our present results suggest that SNARE dysfunction is the initial trigger of mislocalization and accumulation of αSyn, and probably is an important pathomechanism of α-synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197711      PMCID: PMC6621870          DOI: 10.1523/JNEUROSCI.2220-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

Review 1.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

Authors:  M G Spillantini; M Goedert
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Action of complexin on SNARE complex.

Authors:  Kuang Hu; Joe Carroll; Colin Rickman; Bazbek Davletov
Journal:  J Biol Chem       Date:  2002-08-27       Impact factor: 5.157

3.  Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.

Authors:  D D Murphy; S M Rueter; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

4.  A conserved clathrin assembly motif essential for synaptic vesicle endocytosis.

Authors:  J R Morgan; K Prasad; W Hao; G J Augustine; E M Lafer
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein.

Authors:  Deborah E Cabin; Kazuhiro Shimazu; Diane Murphy; Nelson B Cole; Wolfram Gottschalk; Kellie L McIlwain; Bonnie Orrison; Amy Chen; Christopher E Ellis; Richard Paylor; Bai Lu; Robert L Nussbaum
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

6.  Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells.

Authors:  Yoko Shoji-Kasai; Makoto Itakura; Masakazu Kataoka; Saori Yamamori; Masami Takahashi
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

7.  beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

Authors:  E Masliah; E Rockenstein; I Veinbergs; Y Sagara; M Mallory; M Hashimoto; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

8.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

9.  Two distinct mechanisms underlie the stimulation of neurotransmitter release by phorbol esters in clonal rat pheochromocytoma PC12 cells.

Authors:  S Iwasaki; M Kataoka; M Sekiguchi; Y Shimazaki; K Sato; M Takahashi
Journal:  J Biochem       Date:  2000-09       Impact factor: 3.387

Review 10.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02
View more
  25 in total

1.  Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.

Authors:  Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer
Journal:  Biol Psychiatry       Date:  2014-12-19       Impact factor: 13.382

Review 2.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  Cell-Specific Loss of SNAP25 from Cortical Projection Neurons Allows Normal Development but Causes Subsequent Neurodegeneration.

Authors:  Anna Hoerder-Suabedissen; Kim V Korrell; Shuichi Hayashi; Alexander Jeans; Denise M O Ramirez; Eleanor Grant; Helen C Christian; Ege T Kavalali; Michael C Wilson; Zoltán Molnár
Journal:  Cereb Cortex       Date:  2019-05-01       Impact factor: 5.357

4.  Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.

Authors:  Sasuk Kim; Juhee Lim; Yeojin Bang; Jisook Moon; Min-Soo Kwon; Jin Tae Hong; Jeha Jeon; Hyemyung Seo; Hyun Jin Choi
Journal:  Mol Neurobiol       Date:  2017-02-11       Impact factor: 5.590

5.  Aged monkey brains reveal the role of ubiquitin-conjugating enzyme UBE2N in the synaptosomal accumulation of mutant huntingtin.

Authors:  Peng Yin; Zhuchi Tu; An Yin; Ting Zhao; Sen Yan; Xiangyu Guo; Renbao Chang; Lianhe Zhang; Yan Hong; Xiahe Huang; Junxia Zhou; Yingchun Wang; Shihua Li; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2014-10-24       Impact factor: 6.150

6.  PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity.

Authors:  Simote T Foliaki; Victoria Lewis; Abu M T Islam; Matteo Senesi; David I Finkelstein; Laura J Ellett; Victoria A Lawson; Paul A Adlard; Blaine R Roberts; Steven J Collins
Journal:  Biophys J       Date:  2020-06-10       Impact factor: 4.033

Review 7.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

8.  Upregulation of Striatal Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Rats with Excessive Glutamate Release Induced by N-Acetylcysteine.

Authors:  Tomoteru Yamasaki; Maki Okada; Atsuto Hiraishi; Wakana Mori; Yiding Zhang; Masayuki Fujinaga; Hidekatsu Wakizaka; Yusuke Kurihara; Nobuki Nengaki; Ming-Rong Zhang
Journal:  Neurotox Res       Date:  2022-01-04       Impact factor: 3.911

9.  Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia.

Authors:  Vilte E Barakauskas; Annie Moradian; Alasdair M Barr; Clare L Beasley; Gorazd Rosoklija; J John Mann; Boro Ilievski; Aleksandar Stankov; Andrew J Dwork; Peter Falkai; Gregg B Morin; William G Honer
Journal:  Schizophr Res       Date:  2016-03-09       Impact factor: 4.939

10.  Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study.

Authors:  Tomoteru Yamasaki; Masayuki Fujinaga; Kazunori Kawamura; Kenji Furutsuka; Nobuki Nengaki; Yoko Shimoda; Satoshi Shiomi; Makoto Takei; Hiroki Hashimoto; Joji Yui; Hidekatsu Wakizaka; Akiko Hatori; Lin Xie; Katsushi Kumata; Ming-Rong Zhang
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.